Cargando…

CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies

One of the biggest threats we face globally is the emergence of antimicrobial-resistant (AMR) bacteria, which runs in parallel with the lack in the development of new antimicrobials. Among these AMR bacteria pathogens belonging to the ESKAPE group can be highlighted (Enterococcus spp., Staphylococcu...

Descripción completa

Detalles Bibliográficos
Autores principales:	González de Aledo, Manuel, González-Bardanca, Mónica, Blasco, Lucía, Pacios, Olga, Bleriot, Inés, Fernández-García, Laura, Fernández-Quejo, Melisa, López, María, Bou, Germán, Tomás, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300728/ https://www.ncbi.nlm.nih.gov/pubmed/34206474 http://dx.doi.org/10.3390/antibiotics10070756

Ejemplares similares

Viral Related Tools against SARS-CoV-2
por: Fernandez-Garcia, Laura, et al.
Publicado: (2020)

Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases
por: Pacios, Olga, et al.
Publicado: (2020)

Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2
por: Ortiz-Cartagena, Concha, et al.
Publicado: (2022)

Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection
por: Ambroa, Antón, et al.
Publicado: (2022)

Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents
por: Blasco, Lucía, et al.
Publicado: (2023)

CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases
por: Ortiz-Cartagena, Concha, et al.
Publicado: (2023)

Prophage identification and molecular analysis in the genomes of Pseudomonas aeruginosa strains isolated from critical care patients
por: González de Aledo, Manuel, et al.
Publicado: (2023)

Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections
por: Qian, Yizheng, et al.
Publicado: (2023)

Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages
por: Pacios, Olga, et al.
Publicado: (2023)

Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274)
por: Ambroa, Antón, et al.
Publicado: (2020)

Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae
por: Bleriot, Inés, et al.
Publicado: (2023)

Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae
por: Bleriot, Ines, et al.
Publicado: (2020)

Research highlights for issue 6: the CRISPR/Cas revolution
por: Koskella, Britt
Publicado: (2015)

Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens
por: Zohra, Tanzeel, et al.
Publicado: (2021)

Relationship Between Quorum Sensing and Secretion Systems
por: Pena, Rocio Trastoy, et al.
Publicado: (2019)

Phenotypic and Genomic Comparison of Klebsiella pneumoniae Lytic Phages: vB_KpnM-VAC66 and vB_KpnM-VAC13
por: Pacios, Olga, et al.
Publicado: (2021)

The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection
por: Bleriot, Ines, et al.
Publicado: (2022)

Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of Klebsiella pneumoniae Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
por: Bleriot, Ines, et al.
Publicado: (2020)

Introduction of a second “Green Revolution” mutation into wheat via in planta CRISPR/Cas9 delivery
por: Kumagai, Yuya, et al.
Publicado: (2021)

ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic
por: Loyola-Cruz, Miguel Ángel, et al.
Publicado: (2023)

Mexico in revolution
por: Blasco Ibañez, Vicente, 1867-1928
Publicado: (1920)

Quorum and Light Signals Modulate Acetoin/Butanediol Catabolism in Acinetobacter spp.
por: Tuttobene, Marisel Romina, et al.
Publicado: (2019)

The ESKAPE mobilome contributes to the spread of antimicrobial resistance and CRISPR-mediated conflict between mobile genetic elements
por: Botelho, João, et al.
Publicado: (2023)

CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More
por: Ou, Xuejin, et al.
Publicado: (2021)

Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
por: Cervera, Saint T., et al.
Publicado: (2021)

Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii
por: Fernandez-Garcia, Laura, et al.
Publicado: (2018)

Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii
por: Blasco, Lucia, et al.
Publicado: (2019)

Comparative Analysis of CRISPR-Cas Systems in Pseudomonas Genomes
por: Parra-Sánchez, Ángel, et al.
Publicado: (2023)

The CRISPR revolution in fungal biology and biotechnology, and beyond
por: Idnurm, Alexander, et al.
Publicado: (2018)

The Potential Revolution of Cancer Treatment with CRISPR Technology
por: Stefanoudakis, Dimitrios, et al.
Publicado: (2023)

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
por: Santajit, Sirijan, et al.
Publicado: (2016)

Investigating the OXA Variants of ESKAPE Pathogens
por: Pandey, Deeksha, et al.
Publicado: (2021)

Editorial: ESKAPE biofilm: challenges and solutions
por: Tiwari, Vishvanath
Publicado: (2023)

Conditions Under Which Glutathione Disrupts the Biofilms and Improves Antibiotic Efficacy of Both ESKAPE and Non-ESKAPE Species
por: Das, Theerthankar, et al.
Publicado: (2019)

CRISPR-Cas-Led Revolution in Diagnosis and Management of Emerging Plant Viruses: New Avenues Toward Food and Nutritional Security
por: Sharma, Susheel Kumar, et al.
Publicado: (2021)

CRISPR-Cas Controls Cryptic Prophages
por: Song, Sooyeon, et al.
Publicado: (2022)

Eskape Infection Control: Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections (Adv. Sci. 1/2020)
por: Ma, Yu‐Xuan, et al.
Publicado: (2020)

The Reverse Transcriptases Associated with CRISPR-Cas Systems
por: Toro, Nicolás, et al.
Publicado: (2017)

Toxin-Antitoxin Systems in Clinical Pathogens
por: Fernández-García, Laura, et al.
Publicado: (2016)

Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized
por: Gammage, Payam A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_06ocpdqnmeet4lmh6pg5gppva3